Mell LK - Search Results

1

Phase I Trial of Intravenous Oncolytic Vaccinia Virus (GL-ONC1) with Cisplatin and Radiotherapy in Patients with Locoregionally Advanced Head and Neck Carcinoma.

Mell LK, Brumund KT, Daniels GA, Advani SJ, Zakeri K, Wright ME, Onyeama SJ, Weisman RA, Sanghvi PR, Martin PJ, Szalay AA. Mell LK, et al. Clin Cancer Res. 2017 Oct 1;23(19):5696-5702. doi: 10.1158/1078-0432.CCR-16-3232. Epub 2017 Jul 5. Clin Cancer Res. 2017. PMID: 28679776 Clinical Trial.

2

Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer.

Mell LK, Meyer JJ, Tretiakova M, Khramtsov A, Gong C, Yamada SD, Montag AG, Mundt AJ. Mell LK, et al. Clin Cancer Res. 2004 Aug 15;10(16):5546-53. doi: 10.1158/1078-0432.CCR-0943-03. Clin Cancer Res. 2004. PMID: 15328195

3

Predictors of competing mortality in advanced head and neck cancer.

Mell LK, Dignam JJ, Salama JK, Cohen EE, Polite BN, Dandekar V, Bhate AD, Witt ME, Haraf DJ, Mittal BB, Vokes EE, Weichselbaum RR. Mell LK, et al. J Clin Oncol. 2010 Jan 1;28(1):15-20. doi: 10.1200/JCO.2008.20.9288. Epub 2009 Nov 23. J Clin Oncol. 2010. PMID: 19933920

4

Predictors of competing mortality in early breast cancer.

Mell LK, Jeong JH, Nichols MA, Polite BN, Weichselbaum RR, Chmura SJ. Mell LK, et al. Cancer. 2010 Dec 1;116(23):5365-73. doi: 10.1002/cncr.25370. Epub 2010 Aug 24. Cancer. 2010. PMID: 20737562 Free article.

5

A survey of stereotactic body radiotherapy use in the United States.

Pan H, Simpson DR, Mell LK, Mundt AJ, Lawson JD. Pan H, et al. Among authors: mell lk. Cancer. 2011 Oct 1;117(19):4566-72. doi: 10.1002/cncr.26067. Epub 2011 Mar 15. Cancer. 2011. PMID: 21412761 Free PMC article. Clinical Trial.

6

Population-based study of competing mortality in head and neck cancer.

Rose BS, Jeong JH, Nath SK, Lu SM, Mell LK. Rose BS, et al. Among authors: mell lk. J Clin Oncol. 2011 Sep 10;29(26):3503-9. doi: 10.1200/JCO.2011.35.7301. Epub 2011 Aug 15. J Clin Oncol. 2011. PMID: 21844503

7

The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy.

Song S, Rudra S, Hasselle MD, Dorn PL, Mell LK, Mundt AJ, Yamada SD, Lee NK, Hasan Y. Song S, et al. Among authors: mell lk. Cancer. 2013 Jan 15;119(2):325-31. doi: 10.1002/cncr.27652. Epub 2012 Jul 17. Cancer. 2013. PMID: 22806897 Free article.

8

Competing event risk stratification may improve the design and efficiency of clinical trials: secondary analysis of SWOG 8794.

Zakeri K, Rose BS, Gulaya S, D'Amico AV, Mell LK. Zakeri K, et al. Among authors: mell lk. Contemp Clin Trials. 2013 Jan;34(1):74-9. doi: 10.1016/j.cct.2012.09.008. Epub 2012 Oct 11. Contemp Clin Trials. 2013. PMID: 23063467 Free PMC article.

9

Outcomes for patients with cervical cancer treated with extended-field intensity-modulated radiation therapy and concurrent cisplatin.

Jensen LG, Hasselle MD, Rose BS, Nath SK, Hasan Y, Scanderbeg DJ, Yashar CM, Mundt AJ, Mell LK. Jensen LG, et al. Among authors: mell lk. Int J Gynecol Cancer. 2013 Jan;23(1):119-25. doi: 10.1097/IGC.0b013e3182749114. Int J Gynecol Cancer. 2013. PMID: 23262521

10

Race and competing mortality in advanced head and neck cancer.

Zakeri K, MacEwan I, Vazirnia A, Cohen EE, Spiotto MT, Haraf DJ, Vokes EE, Weichselbaum RR, Mell LK. Zakeri K, et al. Among authors: mell lk. Oral Oncol. 2014 Jan;50(1):40-4. doi: 10.1016/j.oraloncology.2013.09.012. Epub 2013 Oct 14. Oral Oncol. 2014. PMID: 24134948

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

203 results

Search Page